Valsartan independent of AT1receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Valsartan independent of AT1receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 18, Issue 10, Pages 2031-2043
Publisher
Wiley
Online
2014-08-11
DOI
10.1111/jcmm.12354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The inflammation highway: metabolism accelerates inflammatory traffic in obesity
- (2012) Amy R. Johnson et al. IMMUNOLOGICAL REVIEWS
- Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes
- (2011) Misaki Iwashita et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
- (2011) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Telmisartan acts through the modulation of ACE-2/ANG 1–7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis
- (2011) Vijayakumar Sukumaran et al. LIFE SCIENCES
- Inflammation and thrombosis in diabetes
- (2011) Katharina Hess et al. THROMBOSIS AND HAEMOSTASIS
- NLRP3 inflammasomes link inflammation and metabolic disease
- (2011) Dominic De Nardo et al. TRENDS IN IMMUNOLOGY
- AMPK in cardiovascular health and disease
- (2010) Najeeb A Shirwany et al. ACTA PHARMACOLOGICA SINICA
- Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
- (2010) Xiaoli Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9–MyD88–ERK1/2 pathway
- (2009) Jin-Sik Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
- (2008) M. R. Dasu et al. DIABETES
- Histamine Induces Egr-1 Expression in Human Aortic Endothelial Cells via the H1 Receptor-mediated Protein Kinase Cδ-dependent ERK Activation Pathway
- (2008) Feng Hao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
- (2008) Stephen C Benson et al. JOURNAL OF HYPERTENSION
- Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats
- (2008) Daisuke Yoshida et al. Journal of the American Society of Hypertension
- Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
- (2007) Yongzhong Wei et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
- (2007) Sridevi Devaraj et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started